DaVita Inc. stock falls after 5.6 percent slide and Bank of America stake

Published on 09/18/2026 at 14:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DaVita Inc. stock traded around USD 183 on September 17, 2026 after a 5.6 percent drop put it among the S&P 500’s top losers. Institutional demand stayed strong as Bank of America Corp DE disclosed a USD 145.06 million stake from Q2 2026.

Modernes Dialysezentrum mit Pflegepersonal und Patienten in heller Klinikumgebung — DaVita Inc. Dialysezentrum mit modernen Behandlungsstühlen und medizinischem Pflegepersonal in Denver, ISIN US23918K1088, Illustration mit AI erstellt.

DaVita Inc. stock (ISIN US23918K1088) is drawing attention after a sharp move, with shares around USD 183 following a 5.6 percent drop on September 17, 2026 that placed the kidney care provider among the top losers in the S&P 500.

Institutional buying offsets sharp share decline

According to MarketBeat on September 18, 2026, Bank of America Corp DE acquired 651,999 DaVita shares in the second quarter of 2026, a position valued at about USD 145,057,000 and representing roughly 1.02 percent of the company.

The same filing summary notes that, based on data compiled by MarketBeat, DaVita currently carries an average analyst rating of Moderate Buy with a consensus target price of USD 233.43, indicating that the Street still sees upside versus the recent level near USD 183.

DaVita among S&P 500’s top losers

As Economic Times reported on September 18, 2026, DaVita appeared in the S&P 500 top losers list with a price of USD 183.09 and a daily decline of 5.56 percent, putting the stock alongside names such as Coterra Energy and T-Mobile US.

A detailed trading recap from MarketBeat on September 17, 2026 states that DaVita shares fell 5.3 percent during that session, trading as low as USD 184.18 and last at USD 183.49, compared with a prior close of USD 193.86 on the New York Stock Exchange.

Valuation and recent trading range

The same MarketBeat overview notes that DaVita opened at USD 183.02 and that the stock has a one-year low of USD 101.00 and a one-year high of USD 247.49, underlining how the current level sits well above the 52-week low but still markedly below the 52-week high.

For investors, the combination of a roughly USD 183 share price, a 5.6 percent single-day drop and a consensus target around USD 233.43 suggests that recent volatility has pushed the stock meaningfully below where analysts expect it to trade, even as large institutional holders such as Bank of America Corp DE increase exposure.

Stock price as of the last completed trading day

Per the NYSE price snapshot cited by MarketBeat, DaVita closed at about USD 183.49 on September 17, 2026, with the move driven by above-average sensitivity to broader market swings and sector rotation within the S&P 500 rather than by any new company-specific earnings release.